Sue Siegel has driven game-changing ideas and powered companies that advance industries and improve lives for more than three decades. With vast experience across industries, she is on the forefront of the Fourth Industrial Revolution and is helping companies identify and seize transformative digital opportunities.
As GE’s Chief Innovation Officer and CEO of GE Ventures, Sue led the development and acceleration of innovation across GE for seven years. She oversaw investment in promising startups, creating and scaling new companies, and commercializing GE’s intellectual property. She also led strategy planning and oversaw the global marketing function.
Before joining GE, Sue was a General Partner at Mohr Davidow Ventures, where she spearheaded investments in personalized medicine, digital health and life sciences. Prior to becoming a venture capitalist, Sue led Affymetrix as President and a board member, where she drove the company’s transformation from a pre-revenue startup to a global, multi-billion-dollar market cap genomics leader. Sue also held executive leadership roles at Bio-Rad, DuPont and Amersham after transitioning to a corporate career from early work in molecular biology and biochemistry.
Valued for her business insights and her background in science, Sue has served as a board member for more than a dozen public and private companies. She is currently a board member at Align Technologies (ALGN), Illumina (ILMN), MIT’s The Engine, and the Kaiser Family Foundation. Additionally, she serves on the advisory boards for Harvard Mass General Brigham Healthcare Innovation, University of California Innovation Council, RAND Health Care and the U.K. National Health Services Digital Academy. She co-chairs Stanford Medicine Board of Fellows.
Sue has also served on numerous nonprofit boards, including Silicon Valley’s Tech Museum of Innovation, Stanford Hospital and Clinics IT Committee, and was part of the founding representative board members of NIH’s National Center for Advancing Translational Sciences. She served on President Obama’s Precision Medicine Initiative Working Group.
A leader in technology and business, Sue has been recognized in Fortune’s “34 Leaders Who Are Changing Health Care” and as one of “The 100 Most Influential Women in Silicon Valley” by Silicon Valley Business Journal. She is an Aspen Institute Henry Crown Fellow and is a featured “Multiplier” in the bestselling book: “Multipliers: How the Best Leaders Make Everyone Smarter.”Back to Innovation Growth Board